In NSCLC cells, a study performed a proteomics analysis where AMPK-interacting proteins were screened and it identified the platelet isoform of phosphofructokinase 1 (PFKP), which is a rate-limiting enzyme. The gene discussed is PRKAA1; the disease is non-small cell lung carcinoma.